Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready
Stellenbosch University is managing 5 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 5 distinct examiners and 5 distinct art units, indicating a broad spread of technical review for the portfolio. The busiest examiner, CONIGLIO, AUDREA JUNE BUCKLEY, is responsible for 1 pending office action, which reflects a highly balanced workload among the assigned personnel. This distribution suggests that the university's intellectual property is being evaluated across multiple specialized divisions.
Since each of the 5 pending office actions is handled by a different individual, the university benefits from a variety of examiner perspectives in the Biotechnology & Pharmaceuticals sector. The fact that 5 distinct examiners are involved means that no single person has a dominant influence over the portfolio's current success. Furthermore, the 5 distinct art units provide a diverse range of departmental standards, and the busiest examiner manages only 1 pending office action, ensuring that the prosecution risk is not concentrated in a single administrative silo.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 1 (20%) |
| §112 only | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CONIGLIO, AUDREA JUNE BUCKLEY | 1 | 53.1% | +20.6% |
| LOUNTOS, GEORGE THEMISTOCLIS | 1 | 57.1% | +60.0% |
| HOFFMAN, ALEXANDER JOSEPH | 1 | 0.0% | +0.0% |
| LOPEZLIRA, ASHLEY NICOLE | 1 | 70.2% | +36.8% |
| COFFA, SERGIO | 1 | 61.1% | +32.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18701026 | RECOMBINANT SACCHAROMYCES CEREVISIAE STRAINS FOR ENZYMATIC HYDROLYSIS OF BIOPLASTIC POLYMERS | LOUNTOS, GEORGE THEMISTOCLIS | — |
| 18699169 | BIOMARKERS FOR DIAGNOSING TUBERCULOSIS | HOFFMAN, ALEXANDER JOSEPH | — |
| 18686122 | A BIOREACTOR FOR CONTACTLESS CO-CULTURING | LOPEZLIRA, ASHLEY NICOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17767734 | IFIT Polypeptides and Uses for Treating Tuberculosis Infection | COFFA, SERGIO | 85d overdue |
| 18867333 | POLYMER SYSTEM FOR FORMING A HYDROGEL | CONIGLIO, AUDREA JUNE BUCKLEY | — |
| 18701026 | RECOMBINANT SACCHAROMYCES CEREVISIAE STRAINS FOR ENZYMATIC HYDROLYSIS OF BIOPLASTIC POLYMERS | LOUNTOS, GEORGE THEMISTOCLIS | — |
| 18686122 | A BIOREACTOR FOR CONTACTLESS CO-CULTURING | LOPEZLIRA, ASHLEY NICOLE | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 1652 | 1 |
| 1677 | 1 |
| 1799 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18867333 | POLYMER SYSTEM FOR FORMING A HYDROGEL | CONIGLIO, AUDREA JUNE BUCKLEY | 1617 | §112 | Non-Final OA | — | Pending | Nov 19, 2024 |
| 18701026 | RECOMBINANT SACCHAROMYCES CEREVISIAE STRAINS FOR ENZYMATIC HYDROLYSIS OF BIOPLASTIC POLYMERS | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §103§112 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18699169 | BIOMARKERS FOR DIAGNOSING TUBERCULOSIS | HOFFMAN, ALEXANDER JOSEPH | 1677 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 05, 2024 |
| 18686122 | A BIOREACTOR FOR CONTACTLESS CO-CULTURING | LOPEZLIRA, ASHLEY NICOLE | 1799 | §102§103§112 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 17767734 | IFIT Polypeptides and Uses for Treating Tuberculosis Infection | COFFA, SERGIO | 1658 | §103 | Non-Final OA | 85d overdue | Pending | Apr 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialStellenbosch University has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.
Audrea June Buckley Coniglio has the most, with 1 of Stellenbosch University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
